Citadel Advisors’s BlackRock Science and Technology Term Trust BSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Sell
9,727
-8,873
-48% -$199K ﹤0.01% 11267
2025
Q4
$421K Buy
18,600
+6,893
+59% +$154K ﹤0.01% 9439
2025
Q3
$259K Buy
+11,707
New +$252K ﹤0.01% 10679
2024
Q1
Sell
-12,124
Closed -$203K 14596
2023
Q4
$203K Buy
+12,124
New +$196K ﹤0.01% 9931
2023
Q1
Sell
-16,022
Closed -$251K 14742
2022
Q4
$251K Buy
+16,022
New +$272K ﹤0.01% 9691

Other funds holding BSTZ

Citadel Advisors's BSTZ Position: Q1 2026 in Review

Citadel Advisors reduced its BlackRock Science and Technology Term Trust (BSTZ) stake by 48% in Q1 2026, selling an estimated $199K and leaving 9,727 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #11267.

Citadel Advisors first reported a position in BSTZ in Q4 2022 and has held it in 5 quarters since. The position peaked at $421K in Q4 2025. 134 funds tracked by Wall St. Rank hold BSTZ as of Q1 2026.

  • Citadel Advisors held 9,727 shares of BlackRock Science and Technology Term Trust worth $215K as of Q1 2026.
  • Citadel Advisors sold 8,873 BlackRock Science and Technology Term Trust shares in Q1 2026, an estimated $199K.
  • BlackRock Science and Technology Term Trust made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11267 holding.
  • Citadel Advisors first reported a position in BlackRock Science and Technology Term Trust in Q4 2022 and has held it in 5 quarters since.
  • Citadel Advisors's BlackRock Science and Technology Term Trust position peaked at $421K in Q4 2025.
  • 134 funds tracked by Wall St. Rank held BlackRock Science and Technology Term Trust as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.